Search News
| 69.06 Delayed Data As of 4:02pm ET |  +0.21 / +0.31%Today’s Change | 52.83 Today|||52-Week Range 69.24 | +22.73% Year-to-Date |
| Previous close | 68.85 |
| Today’s open | 68.78 |
| Day’s range | 68.70 - 69.24 |
| Volume | 7,847,116 |
| Average volume (3 months) | 9,963,798 |
| Market cap | $179.2B |
| Earnings growth (last year) | -38.30% |
| Earnings growth (this year) | +7.32% |
| Earnings growth (next 5 years) | +7.11% |
| Revenue growth (last year) | +1.23% |
| P/E ratio | 137.8 |
| Price/Sales | 3.87 |
| Price/Book | 5.29 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.85 | +1.03% |
| PFEPfizer | +0.67 | +1.62% |
| SNYSanofi | +0.79 | +1.92% |
| ABBVAbbVie | +0.59 | +0.60% |
| Next reporting date | October 26, 2018 |
| EPS forecast (this quarter) | $1.12 |
| Annual revenue (last year) | $40.0B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 5.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
